moved:
That, in the opinion of the House, the government should help ensure that patients suffering from Multiple sclerosis (MS), and their families and caregivers, have access to the information they need to make informed decisions in the management of their condition by ensuring that: (a) the MS monitoring system currently being developed by the Canadian Institute for Health Information contain specific and useful information, accessible directly to patients, on the risks, benefits, and other relevant aspects relative to undergoing surgical treatment for chronic cerebro-spinal venous insufficiency (CCSVI); (b) departments, agencies and programs work closely with provincial and territorial counterparts, with health professionals associations, such as the Royal College of Physicians and Surgeons, and with patient groups, such as the MS Society of Canada, on the sharing of up-to-date research-based information on the nature of CCSVI and its link to MS; and (c) the government’s two advisory boards dealing with MS ensure the patients’ concerns and views are well represented and heard at future meetings.
Madam Speaker, I note that it is a very complicated motion. I would have preferred a simpler one, but I think it was required to get the message across.
I am honoured to speak to my private member's Motion No. 274. It is a motion to help ensure that patients suffering from multiple sclerosis, MS, and their families and caregivers have access to the information they need to make informed decisions on the management of their condition.
In most situations, of course, they would get this information from their doctors. However, for some MS sufferers in the advanced stages of the disease, they simply cannot get the information they need in order to make the decision on whether to have the liberation therapy or CCSVI treatment. If they have already decided to have the surgery, they need to decide where to have it done. I will explain why their doctors cannot give them this information.
First, this treatment is not available in Canada because it has not been approved as a treatment for MS. It is simply too new.
Second, most doctors simply do not know enough about the treatment to give patients advice on it. Because the science is not complete, it would be difficult for doctors to advise patients to have a procedure done outside Canada.
The purpose of my private member's motion is to establish an information portal to allow MS sufferers who are considering having the liberation therapy outside Canada to get anecdotal information from others who have already had the procedure done. This would also allow people who have already decided to have the treatment to obtain information about the process, particularly about the results, in various clinics outside Canada. Of the many people suffering from MS that I have talked to, especially those who have had the procedure done, there seem to be different results from different clinics.
To be clear, my private member's motion is meant to fill a desperate need for information, just over the next two to three years until the scientific processes are complete or at least far enough along to release the information to the public.
What is MS?
Despite the amount of research to date, little is known about the disease or what causes it. While there are different theories, there are still questions about what causes MS.
There are four types of MS identified and a wide variety of symptoms for MS patients. It is an unpredictable disease that can affect a patient's vision, hearing, memory, balance and mobility. The most common form of MS is defined by attacks which are followed by complete or partial recovery. Eventually, the part of the body that is affected by the attacks loses its ability to recover and scarring begins. This can lead to more permanent damage. At the point when MS is diagnosed, the severity, the progression or the specific symptoms that might be suffered simply cannot be predicted.
For some types of MS, a sufferer will be immobilized to the point of needing constant care. Even if the MS sufferers are still very young, they are often put into institutions intended for disabled elderly people. They find this to be very difficult to take and they are looking for some way to get around it. These are primarily the people who are looking to this liberation therapy for help.
In June 2009, Dr. Paolo Zamboni from Italy published his first study that involved approximately 65 patients who underwent the CCSVI treatment. The CCSVI treatment is also referred to as liberation therapy or liberation treatment. It is a surgery that improves blood flow in certain veins which carry blood from the brain or upper spinal column. CCSVI itself is actually a restriction of the flow of blood drainage from the brain and spinal column. The treatment frees up this flow.
Dr. Zamboni's treatment initially came from the concept of standard angioplasty which is used widely in Canada and around the world. This is a procedure where doctors use balloons to open blocked arteries that carry blood from the heart. Dr. Zamboni teamed up with a vascular surgeon, Dr. Galeotti. They began treating patients to see if endovascular surgery using these balloons to open veins would repair flow in the vessels and reduce MS symptoms. The study resulted in patients' experiencing a reduced number of attacks, fewer brain lesions that define MS, and most importantly, an overall improvement in the quality of life of many of the patients.
Unfortunately, when the veins start to narrow again, the patients' symptoms start to return. Since Dr. Zamboni's first study, the process has evolved and is different in different clinics. Therefore, when people are considering getting this procedure done, or have decided to have it done and are deciding where, they will benefit from even anecdotal information about the results achieved at different clinics in the United States or around the world. This procedure is unavailable in Canada.
Why have I chosen this topic for my private member's motion? Because I will only get one chance in the four and a half years of this Parliament to put forth a motion and have it debated. In fact, probably not everyone in the House will have that opportunity, even in this Parliament which will be longer than usual. Why have I chosen this motion on this issue? It is for many reasons, and the most compelling reasons come from my constituents. Groups in Lloydminister and Wainwright, and individuals from across my constituency have contacted me to tell me how desperate they are for information to help them make this decision.
For several months, I have been meeting with not only constituents, but with the Minister of Health, representatives from the Canadian Institute for Health Information or CIHI, doctors researching CCSVI treatment and other treatments, representatives from the MS Society and a lot of other people.
From these discussions, it was clear that there is great hope in the CCSVI treatment. People from around the world are working to get more answers regarding the treatment. In fact, our government has implemented a very comprehensive plan which is being implemented on an accelerated timeline, beyond anything I could have imagined done by government, to determine the potential of this procedure.
The people in the Lloydminster group are great people. They presented their case so well and I simply could not say no. That is why I am here today debating this issue.
The CCSVI treatment is new. It has brought new hope to many MS sufferers, particularly those in the later stages of progressive types of MS. Because the treatment is not yet offered in Canada, Canadians seeking this treatment must travel to the United States, Mexico, Poland, Cost Rica and a wide range of countries. Despite the high cost of getting the treatment abroad and the difficulty in travelling, MS patients are forced to undertake the cost in order to get their lives back. This is the kind of terminology I have heard from people who have had this therapy and from others who are looking at the possibility of it.
Our government is currently working on clinical trials, studying this liberation therapy and its potential at an unprecedented rate. We are including information from around the world. Despite all the work being done, Canadians with MS are questioning whether they should have the treatment and if so, where. The purpose of my motion is to provide this information portal where people considering the process can read testimonials based on a wide range of fairly comprehensive and specific questions.
Individuals can then take this information and have at least something to help them with this difficult decision. Information is available right now online, but it is very limited. The Lloydminster group was very lucky. About a dozen people have had this procedure someplace around the world. People can talk to them, and they do that, but they are looking for more information. That is the purpose of my private member's motion.
This database would be confidential, of course, and would not advocate that patients have this liberation therapy done. The procedure has not been well enough proven to do that. It is simply meant to be testimonials by people who have had it done.
Instead, it would allow people to access information that may assist them in their decision-making process. This information would come from others who have had the therapy done at various clinics and can comment on such things as the clinic, the doctor, how long ago the therapy was done and all the various things that make a real difference.
Unbelievably, Zamboni only came out with his study of this result a little over two years ago. In that two years, there have been incredible progression and improvements and changes made, more in some clinics than in others. That is the type of information that is meant to be provided on the database.
It is extraordinary that a report released just two years ago has had this kind of impact. There is a lot of controversy surrounding the results, but it is impossible to ignore the results.
I have spoken to MS patients and their families first-hand about the effects of this treatment, and most of them have found quite remarkable improvement, especially in clarity of thinking. We can imagine living in a fog for years and all of sudden being able to think clearly. That is one of the greatest impacts. So is improved mobility. There are many benefits, although I have spoke to a couple of people who did not have any noticeable results, so this is not a panacea. It is not perfect, but it is something.
In describing this to me, some have said they don't know what the findings will be after the trials are conducted, but what they do know is that this CCSVI treatment has given them hope. They say they have something to live for again. Others have said it has given them their life back.